Private Capital Group, LLC Fate Therapeutics Inc Transaction History

Private Capital Group, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 28, 2022	SELL	$17.78 - $42.39 $320 - $763	-18 Closed	0 $0
Q1 2022 Apr 21, 2022	SELL	$29.67 - $60.28 $178 - $361	-6 Reduced 25.0%	18 $1,000
Q4 2021 Jan 24, 2022	BUY	$47.84 - $64.34 $574 - $772	12 Added 100.0%	24 $1,000
Q3 2021 Oct 13, 2021	BUY	$59.27 - $95.73 $711 - $1,148	12 New	12 $1,000

178

124M

222K

48.6K

Ticker FATE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,000,304
Market Cap $316M
Description
Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell...

Get notified when there are updates to the investment portfolio of Private Capital Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Private Capital Group, LLC with notifications on news.